Cargando…

Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report

INTRODUCTION: Anesthetic management of patients with Duchenne muscular dystrophy (DMD) is complicated because these patients are more sensitive to nondepolarizing neuromuscular blocking agents (NMBAs) and are vulnerable to postoperative complications, such as postoperative residual curarization and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Eun, Chun, Hea Rim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	3300
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380262/ https://www.ncbi.nlm.nih.gov/pubmed/28353578 http://dx.doi.org/10.1097/MD.0000000000006456

Ejemplares similares

Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis
por: Won, Young Ju, et al.
Publicado: (2016)

Incomplete recovery from rocuronium-induced muscle relaxation in patients with amyotrophic lateral sclerosis using sugammadex: A case report
por: Chun, Hea Rim, et al.
Publicado: (2020)

Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study
por: An, Jihyun, et al.
Publicado: (2020)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Anesthetic management with remimazolam for a pediatric patient with Duchenne muscular dystrophy
por: Horikoshi, Yuta, et al.
Publicado: (2021)

The effect of dexamethasone on sugammadex reversal of rocuronium-induced neuromuscular blockade in surgical patients undergoing general anesthesia: A systematic review and meta-analysis
por: Lim, Byung Gun, et al.
Publicado: (2021)

Effects of methylprednisolone on the duration of rocuronium-induced neuromuscular block: A randomized double-blind trial
por: Geng, Weilian, et al.
Publicado: (2017)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
por: Kashiwai, Akihiro, et al.
Publicado: (2012)

Use of sugammadex in a patient with progressive muscular atrophy and in a patient with amyotrophic lateral sclerosis: Case report
por: Yoo, Jae Hwa, et al.
Publicado: (2017)

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
por: Koo, Chang-Hoon, et al.
Publicado: (2020)

Sugammadex induced bradycardia and hypotension: A case report and literature review
por: Teng, I-Chia, et al.
Publicado: (2021)

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020)

Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
por: Kang, Woon Seok, et al.
Publicado: (2017)

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study
por: Fábián, Ákos I., et al.
Publicado: (2019)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020)

Laparoscopic gynecological surgery in an adult woman with Becker muscular dystrophy performed with sevoflurane with cisatracurium anesthesia: A case report
por: Zhou, Shi-Yao, et al.
Publicado: (2020)

Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015)

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis
por: Ji, Sang‐Hwan, et al.
Publicado: (2022)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
por: Ji, Sang-Hwan, et al.
Publicado: (2023)

Fiberoptic bronchoscopic treatment of blood aspiration and use of sugammadex in a patient with epistaxis: A case report
por: Ryu, Taeha, et al.
Publicado: (2018)

Optimal dose of combined rocuronium and cisatracurium during minor surgery: A randomized trial
por: Park, Woo Young, et al.
Publicado: (2018)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient
por: Iwasaki, Hajime, et al.
Publicado: (2013)

Rapid arousal from anaesthesia after reversal of deep rocuronium-induced neuromuscular block with sugammadex in a neuroradiological procedure
por: Giuffrida, Matteo, et al.
Publicado: (2021)

The utility of bispectral index monitoring for prevention of rocuronium-induced withdrawal movement in children: A randomized controlled trial
por: Lim, Byung Gun, et al.
Publicado: (2017)

Clinically suspected anaphylaxis induced by sugammadex in a patient with Weaver syndrome undergoing restrictive mammoplasty surgery: A case report with the literature review
por: Bedirli, Nurdan, et al.
Publicado: (2018)

Unexpected delayed reversal of rocuronium-induced neuromuscular blockade by sugammadex: A case report and review of literature
por: Wang, Hao-Chen, et al.
Publicado: (2022)

Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report-
por: Kim, Gunn Hee, et al.
Publicado: (2019)

Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis
por: Staikou, Chryssoula, et al.
Publicado: (2017)

Comparison of the Efficacy and Safety of Adamgammadex with Sugammadex for Reversal of Rocuronium-Induced Neuromuscular Block: Results of a Phase II Clinical Trial
por: Jiang, Yingying, et al.
Publicado: (2022)

Repeat dosing of rocuronium-sugammadex: unpredictable
por: Kim, Yoon-Hee
Publicado: (2014)

Limited effect of sugammadex on postoperative pulmonary complications in patients undergoing spine surgery in prone position intraoperatively: A retrospective analysis of matched cohort data
por: Ko, Eunji, et al.
Publicado: (2023)

Comparison of postoperative coagulation profiles and outcome for sugammadex versus pyridostigmine in 992 living donors after living-donor hepatectomy
por: Moon, Young-Jin, et al.
Publicado: (2018)

Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively
por: Song, Sejin, et al.
Publicado: (2014)

A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU
por: Bologheanu, Răzvan, et al.
Publicado: (2022)

Sinus pause during nerve integrity monitoring tube insertion following anesthetic induction with a low-dose neuromuscular blocking agent: A CARE-compliant case report
por: Byun, Sung-Hye, et al.
Publicado: (2021)

Sugammadex is effective in reversing rocuronium in the presence of antibiotics
por: Hudson, Mark E, et al.
Publicado: (2014)

Neuronal Effects of Sugammadex in combination with Rocuronium or Vecuronium
por: Aldasoro, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_prdq0htnnsu14kutf2qqppdl16